Understanding the distinct role of PI3K(p110α) in cancer and the heart to prevent chemotherapy-induced cardiotoxicity: mechanisms and therapeutic opportunities.

Belkin TG, Tham YK, Edgley AJ, McMullen JR

Open source

DOI
10.3389/fcvm.2026.1891148
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1891148,
  title = {Understanding the distinct role of PI3K(p110α) in cancer and the heart to prevent chemotherapy-induced cardiotoxicity: mechanisms and therapeutic opportunities.},
  author = {Belkin TG and Tham YK and Edgley AJ and McMullen JR},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1891148},
  url = {https://doi.org/10.3389/fcvm.2026.1891148}
}

RIS

TY  - JOUR
TI  - Understanding the distinct role of PI3K(p110α) in cancer and the heart to prevent chemotherapy-induced cardiotoxicity: mechanisms and therapeutic opportunities.
AU  - Belkin TG
AU  - Tham YK
AU  - Edgley AJ
AU  - McMullen JR
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1891148
UR  - https://doi.org/10.3389/fcvm.2026.1891148
ER  - 

APA

TG, B., YK, T., AJ, E., & JR, M. (2026). Understanding the distinct role of PI3K(p110α) in cancer and the heart to prevent chemotherapy-induced cardiotoxicity: mechanisms and therapeutic opportunities.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1891148

Source records